Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionGrimes & Company, Inc.
Latest Disclosed Ownership8,040 shares
Latest Disclosed Value $ 7,395,214
Grimes & Company, Inc. reports 20.32% increase in ownership of LLY / Eli Lilly and Company

On April 21, 2026 - Grimes & Company, Inc. filed a 13F-HR form disclosing ownership of 8,040 shares of Eli Lilly and Company (US:LLY) valued at $7,394,951 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 6,682 shares of Eli Lilly and Company. This represents a change in shares of 20.32% during the quarter. The current value of the position is $8,673,391 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ELI LILLY COM 532457108 8,040 1,358 20.32 7,395 2.98 0.2047
2026-02-03 2025-12-31 13F ELI LILLY COM 532457108 6,682 472 7.60 7,181 51.59 0.1716
2025-10-27 2025-09-30 13F ELI LILLY COM 532457108 6,210 1,551 33.29 4,738 30.46 0.1170
2025-07-22 2025-06-30 13F ELI LILLY COM 532457108 4,659 321 7.40 3,632 1.37 0.0988
2025-04-17 2025-03-31 13F ELI LILLY COM 532457108 4,338 186 4.48 3,583 11.76 0.1107
2025-01-21 2024-12-31 13F ELI LILLY COM 532457108 4,152 79 1.94 3,206 -11.17 0.0924
2024-10-22 2024-09-30 13F ELI LILLY COM 532457108 4,073 326 8.70 3,608 6.37 0.0976
2024-07-22 2024-06-30 13F ELI LILLY COM 532457108 3,747 -85 -2.22 3,393 13.79 0.1015
2024-04-17 2024-03-31 13F ELI LILLY COM 532457108 3,832 -1,047 -21.46 2,981 4.82 0.0916
2024-01-24 2023-12-31 13F ELI LILLY COM 532457108 4,879 952 24.24 2,844 34.85 0.0942
2023-10-19 2023-09-30 13F ELI LILLY COM 532457108 3,927 20 0.51 2,109 15.12 0.0816
2023-07-19 2023-06-30 13F LILLY ELI COM 532457108 3,907 -13 -0.33 1,832 36.11 0.0650
2023-04-20 2023-03-31 13F LILLY ELI COM 532457108 3,920 131 3.46 1,346 -2.89 0.0552
2023-01-25 2022-12-31 13F LILLY ELI COM 532457108 3,789 10 0.26 1,386 13.42 0.0585
2022-10-28 2022-09-30 13F LILLY ELI COM 532457108 3,779 18 0.48 1,222 0.25 0.0638
2022-07-22 2022-06-30 13F LILLY ELI COM 532457108 3,761 13 0.35 1,219 13.61 0.0615
2022-05-06 2022-03-31 13F LILLY ELI COM 532457108 3,748 -134 -3.45 1,073 0.09 0.0501
2022-05-06 2022-03-31 13F LILLY ELI COM 532457108 3,806 1,090
2022-02-01 2021-12-31 13F LILLY ELI COM 532457108 3,882 0 0.00 1,072 19.51 0.0491
2021-11-08 2021-09-30 13F LILLY ELI COM 532457108 3,882 54 1.41 897 2.16 0.0390
2021-08-04 2021-06-30 13F LILLY ELI COM 532457108 3,828 14 0.37 878 23.14 0.0381
2021-05-12 2021-03-31 13F LILLY ELI COM 532457108 3,814 -794 -17.23 713 -8.35 0.0343
2021-02-02 2020-12-31 13F Eli Lilly and COM 532457108 4,608 0 0.00 778 13.91 0.0404
2020-11-12 2020-09-30 13F Eli Lilly and COM 532457108 4,608 -16 -0.35 683 -10.01 0.0437
2020-07-31 2020-06-30 13F Eli Lilly and COM 532457108 4,624 0 0.00 759 18.41 0.0527
2020-05-05 2020-03-31 13F Eli Lilly and COM 532457108 4,624 253 5.79 641 11.67 0.0585
2020-02-05 2019-12-31 13F Eli Lilly and COM 532457108 4,371 29 0.67 574 18.11 0.0376
2019-11-05 2019-09-30 13F Eli Lilly and COM 532457108 4,342 0 0.00 486 1.04 0.0346
2019-07-30 2019-06-30 13F Eli Lilly and COM 532457108 4,342 -57 -1.30 481 -15.76 0.0365
2019-05-02 2019-03-31 13F Eli Lilly and COM 532457108 4,399 177 4.19 571 16.77 0.0448
2019-02-01 2018-12-31 13F Eli Lilly and COM 532457108 4,222 -125 -2.88 489 4.94 0.0477
2018-11-09 2018-09-30 13F Eli Lilly and COM 532457108 4,347 50 1.16 466 26.98 0.0373
2018-08-10 2018-06-30 13F Eli Lilly and COM 532457108 4,297 800 22.88 367 35.93 0.0324
2018-05-07 2018-03-31 13F Eli Lilly and COM 532457108 3,497 3,497 270 0.0262
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.